Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels By Reuters
[ad_1] (Reuters) -Verve Therapeutics said on Tuesday that it had paused enrollment for an early-stage study testing its experimental gene editing therapy for high cholesterol...
Vera Therapeutics shares target raised by Wedbush, cites ‘ORIGIN 3’ enrollment By Investing.com
[ad_1] © Reuters. On Thursday, Wedbush maintained its Outperform rating on Vera Therapeutics (NASDAQ:VERA) and increased the shares price target to $34 from $21. The...
Cardano’s Founder Charles Hoskinson Exposed for Misleading Claims About His Ph.D. Enrollment By DailyCoin
[ad_1] Cardano’s Founder Charles Hoskinson Exposed for Misleading Claims About His Ph.D. Enrollment Cardano’s (ADA) founder Charles Hoskinson got in a heated discussion on Twitter...